Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Prions, vCJD and the Immune System Relay

Published: Friday, December 06, 2013
Last Updated: Friday, December 06, 2013
Bookmark and Share
BBSRC is helping to shed new light on variant Creutzfeldt-Jakob disease.

Despite more than a decade's worth of research, many aspects of variant Creutzfeldt-Jakob disease (vCJD) still remain a mystery. This fatal neurodegenerative disease of the brain is often referred to as the human form of bovine spongiform encephalopathy (BSE), known to most as 'mad cow disease'.

vCJD was first described in 1986 and was attributed to humans eating meat from infected cattle. The exact root of the disease is still unknown, but proteins known as prions are believed to be the causative agent. A build up of misfolded prions in the brain causes the progressive death of neurons, for which there is no cure. The brains of people that have died of the disease look sponge-like when viewed under a microscope, hence the word 'spongiform' in BSE.

Misfolding proteins

The way that a prion infection spreads is debated. The prion mode of action is very different to bacteria and viruses as they are simply proteins, devoid of any genetic material. Once a misfolded prion enters a healthy person – potentially by eating infected food – it converts correctly-folded proteins into the disease-associated form. To date, nobody knows quite how this happens.

vCJD is by no means the only form of prion disease in humans. Sporadic CJD (sCJD) is the most common, causing around 1-2 deaths per 1,000,000 people in the UK each year, generally in those over the age of 60. vCJD is also rare – despite an estimated 400-500,000 BSE infected cattle entering the food chain in the 1980's – with only 177 definite or probable cases having been reported to date. Unlike sCJD, the majority of those affected were young (~26 years old).

Initially, this age discrepancy was thought to be related to dietary habits, with young people more likely to be eating food with a high risk of contamination. No strong evidence for this was found (old people eat pies and burgers, too).

The immune system relay

New research from scientists at The Roslin Institute – which is strategically-funded by BBSRC – and published in the Journal of General Virology, is helping us to understand why vCJD appears to mainly affect the young.

Having a healthy immune system seems to be central to vCJD development. Indeed, mice that lack a functional immune system have a lower susceptibility to prion disease. The misfolded prions appear to hijack the defence system that protects against bacterial and viral infection, using it to gain access to the nervous system and, ultimately, the brain.

Dr Neil Mabbott, one of the co-authors of the study, describes the movement of the prions as 'a relay', which begins in the small intestine.

In order to ascertain whether there are any pathogens in the small intestine and, if so, what response needs to be mounted, the body uses an 'antigen sampling' system (kind of a built in dipstick) to see what is present.

This system is the point of entry for the misfolded prions, allowing them to slip in the body's lymphatic system. Once there, they attach to the surface of immune cells known as follicular dendritic cells (FDCs), and replicate by causing normal prion proteins to misfold into the disease-causing version.

Through methods unknown, the misfolded prions escape the surface of the FDCs, moving into the nerves, and spread through the spinal cord and vagus nerve to the brain where the real damage begins.

The new research studied two groups of mice: 32 between six and eight weeks of age and 29 around ninety weeks old (very old for a mouse). These two groups of mice were injected with prions from a cow known to have been infected with BSE.

Dropping the baton?

Within a few months, prions had accumulated in the lymph nodes and spleen of the young mice, although they did not show any signs of disease. Over a year later, the majority of those tested showed classic signs of prion neurodegeneration.

In contrast, none of the old mice developed any clinical disease, all died of natural age-related diseases. Only one of the 29 older aged mice showed any sign of having prions in its brain and this was only in a small, localised area. Given that most of these adult mice died before the time it takes to develop prion disease, it can't be ruled out that they would have developed an infection if they'd lived long enough, although there was no evidence of any prion-related neurodegeneration.

Despite there being no evidence of prions in the elderly mice's brains, there were detectable levels in their spleens, albeit at lower levels than in the younger mice. Dr Mabbott suggests that this may be because one of the relay steps is missing, or working less efficiently, in the older mice.

The research, funded by the BBSRC and the  European Commission: Seventh Framework Programme (FP7) , builds on previous work that showed how the microarchitecture of the mice's spleen – part of the antigen sampling system – deteriorates with age, as do the numbers of FDCs, leaving less for the prions to replicate on.

Error bars

While this study does provide us with further background into vCJD, a disease that remains much of a mystery, we need to remember that the mice being used in the study are clearly not humans, so any parallels drawn between the two species must be done carefully. That said, recent research published in the BMJ suggests that levels of abnormal vCJD prions in humans appear to be higher than we previously thought.

Researchers investigated over 30,000 stored appendix samples, removed during operations in the UK between 2000 and 2012, of which 16 showed evidence of abnormal prions. Although a small number, the authors of the paper suggest that this indicates a prevalence of 493 people per million in the UK with abnormal prions, higher than the total number of confirmed vCJD cases (177) to date.

In addition to showing the importance of ageing to susceptibility of prion disease, Dr Mabbott's work has also uncovered the effects that getting old has on the immune system. He has recently been awarded a grant from the BBSRC to further investigate the mechanisms that cause the immune system to break down, which may ultimately help to improve people's health as they get older.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Drugs Used to Treat Lung Disease Work With the Body Clock
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective.
Thursday, August 14, 2014
Researchers Have a Nose for How Probiotics Could Affect Hay Fever
A study has shown that a daily probiotic drink changed how cells lining the nasal passages of hay fever sufferers reacted to a single out-of-season challenge.
Thursday, November 28, 2013
New Technique for Developing Drugs
An international team of researchers have created a new drug for possible use against heart disease, inflammation and other illnesses.
Monday, November 18, 2013
Breaking up the Superbugs’ Party
The fight against antibiotic-resistant superbugs has taken a step forward thanks to a new discovery by scientists.
Friday, August 16, 2013
£60,000 Competition to Recognise Innovative Scientists Launched by BBSRC
Innovator of the Year 2014 competition launched by BBSRC to recognise and reward scientist's whose excellent science and innovations are delivering real world impact.
Friday, July 12, 2013
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
New Antibody Therapy Permanently Blocks SIV Infection
An international research team has developed an effective treatment strategy against the HIV-like Simian Immunodeficiency Virus (SIV) in rhesus macaques.
Contribution Increases by Tenfold The Mouse Mutation Resources of One Type Available
The repository provides academic researchers with unique genetic models that are unavailable commercially.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
DNA Vaccines Protect Monkeys Against Zika Virus
Two experimental Zika virus DNA vaccines developed by NIH scientists protected monkeys against Zika infection.
Rare Flu-Thwarting Mutation Discovered
Study finds protein mutation, that is encoded by influenza, causes the virus to lose any defence against the immune system.
Mapping the Human Immune System
Researchers try to harness supercomputers to create the first map of the human immune system.
Antibody Drug Conjugates May Help Personalize Radiotherapy
Biomarker-driven study shows promise in sensitizing HER2 positive tumors to radiation and chemotherapy.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos